Altieri Richard M. 4
4 · Oxford Immunotec Global PLC · Filed Jan 26, 2018
Insider Transaction Report
Form 4
Altieri Richard M.
Chief Financial Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2018-01-24$0.18/sh+152,330$27,419→ 202,965 total - Exercise/Conversion
Share Option (Right to Buy)
2018-01-24−152,330→ 0 totalExercise: $0.18Exp: 2022-03-31→ Ordinary Shares (152,330 underlying)
Footnotes (1)
- [F1]Options became fully exercisable on March 31, 2016.